We have seen FRE (Firebrick) go straight into the US with a simple description of Nasodine being a nasal disinfectant, and no attempt to get FDA approval.
This article in Newsweek in the crucial mid 2021 shows what a hard time antiviral nasal sprays have had in the US, whilst there was an all out pursuit of VACCINES and Big Pharma was of course testing expensive Paxlovid.
So maybe Starpharma management is wise in not pursuing US authorities for EUS - FDA & CDC.
This paragraph is particularly telling "...The FDA also asked for a safety trial. But over-the-counter nasal sprays have been on the market for years with almost no serious safety concerns. "It just makes no sense," says a source familiar with the company's communications with the agency. ''They want mountains from us and a molehill from the drug makers."..."
SPL Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
